bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.01.06.697946

Phenotypic dynamics and behaviors of neutrophils during barrier challenge

Abstract

Neutrophils are intrinsically antimicrobial innate immune cells, but they have recently been observed to play diverse roles across various conditions. The concept of neutrophil heterogeneity has thus emerged, yet a fundamental understanding of the mechanisms and processes underlying neutrophil diversity in vivo is lacking. Here, we interrogated neutrophils native propensities to diversify by studying them in the setting of host defense to barrier challenge. Using both high-parameter, high throughput methods and intravital microscopy, we tracked cellular dynamics, identity, and behaviors and asked how these aligned with critical host defensive functions. We found that neutrophil diversity was underscored by both turnover and plasticity of cells within an infection site, and that environment-specific adaptation occurred rapidly upon extravasation and swarm initiation. The population-level phenotypic landscape shifted considerably through phases of inflammation initiation, peak, and resolution; and adaptation varied substantially between infections and aseptic wounds. Like mature neutrophils, immature neutrophils were capable of phenotypic adaptation in infection sites but were deficient in host defense functions. We unexpectedly identified a novel population of CD101-low, mature neutrophils, expressing elevated levels of PD-L1 and ICAM-1, that was associated with key antimicrobial effector functions and most pronounced during the neutrophil response to large or recalcitrant challenge. Our findings highlight that neutrophil specification is rapid and environment-dependent, and that specific phenotypes are linked to critical host defensive behaviors and functions in vivo.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Siwicki, M., Shim, H. B., Newton, M., Lee, W. Y., Kubes, P.. 2026-01-07. Phenotypic dynamics and behaviors of neutrophils during barrier challenge. https://doi.org/10.64898/2026.01.06.697946

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗